1.
Megias-Vericat JE, Martínez-Cuadrón D, Martínez López J, Bergua JM, Tormo M, Serrano J, González A, Pérez de Oteyza J, Vives S, Vidriales B, Herrera P, Vera JA, López Martínez A, De la Fuente A, Amador ML, Hernández-Rivas J Ángel, Fernández M Ángeles, Cerveró CJ, Morillo D, Hernández Campo P, Gorrochategui J, Primo D, Rojas JL, Guenova M, Ballesteros J, Sanz M Ángel, Montesinos P. DIFFERENCES IN EX-VIVO CHEMOSENSITIVITY TO ANTHRACYCLINES IN FIRST LINE ACUTE MYELOID LEUKEMIA. Mediterr J Hematol Infect Dis [Internet]. 2019Feb.26 [cited 2020Jul.5];11(1):e2019016. Available from: http://mjhid.org/index.php/mjhid/article/view/2019.016